Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY)

CAPS Rating: 2 out of 5

A development stage company focuses on the discovery and development of oncolytic viruses for the treatment of cancers.

Recs

0
Player Avatar pchop123 (80.37) Submitted: 4/8/2013 10:11:00 AM : Underperform Start Price: $2.92 ONCY Score: +3.74

maybe looking at more dilution soon

Featured Broker Partners


Advertisement